All
Development of a Combination Microbicide Gel Formulation Containing IQP-0528 and Tenofovir for the Prevention of HIV Infection
Ham AS, Ugaonkar SR, Shi L, Buckheit KW, Lakougna H, Nagaraja U, Gwozdz G, Goldman L, Kiser PF, Buckheit RW Jr. Journal of Pharmaceutical Sciences. 101, no. 4 (April 2012):1423-35. Epub 6 Jan 2012. More »
HIV Incidence Remains High in KwaZulu-Natal, South Africa: Evidence from Three Districts.
Nel A, Mabude Z, Smit J, Kotze P, Arbuckle D, Wu J, van Niekerk N, van de Wijgert J. PLOS ONE. 7, no. 4 (April 2012): e35278. More »
Preventive misconception as a motivation for participation and adherence in microbicide trials: evidence from female participants and male partners in Malawi and Zimbabwe.
Woodsong C, Alleman P, Musara P, Chandipwisa A, Chirenje M, Martinson F, Hoffman I. AIDS and Behavior. 16, no. 3 (April 2012):785-90. Epub: 24 August 2011. More »
Pharmacokinetics of Tenofovir following Intravaginal and Intrarectal Administration of Tenofovir Gel to Rhesus Macaques.
Nuttall J, Kashuba A, Wang R, White N, Allen P, Robert J, Romano J. Antimicrobial Agents and Chemotherapy. 56, no. 1 (January 2012):103-9. Epub 10 October 2011. More »
2012 IPM Annual Report: From Science to Solutions
IPM's 2012 annual report features our progress developing new HIV prevention tools and multipurpose prevention technologies for women and takes a look at our plans for the future. Available below in... More »